Ethics/Regulatory

UK government creates working group to improve research transparency

Thursday, September 15, 2011 11:48 AM

With momentum building for open-access publishing and debate continuing to rage about access to clinical trial data, the UK government is setting up an independent working group to look at how UK-funded research findings can be made more widely available, according to PharmaTimes.

More... »

Report: EMA’s system of comparing drugs is flawed

Friday, September 9, 2011 11:52 AM

The European system of comparing drugs against placebo and not against a comparator is flawed, according to researchers at the London School of Economics, reported InPharm.

More... »

New Zealand to streamline ethics committee review system

Friday, September 9, 2011 10:17 AM

The New Zealand government will work over the next 10 months to streamline and simplify processes for ethics committee reviews of clinical trials, according to PharmaTimes.

More... »

FDA’s new guidance on monitoring clinical trials strongly encourages taking a risk-based approach

Monday, September 5, 2011 08:02 AM

Arisk-based approach to monitoring clinical trials: It’s the way to go now.

More... »

FDA approves Lupin’s UltramR ER

Wednesday, August 31, 2011 01:04 PM

Lupin Pharmaceuticals has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200 and 300 mg strengths. Lupin will begin shipping its Tramadol ERshortly.

More... »

NIH finalizes changes in conflict of interest rules

Wednesday, August 24, 2011 02:12 PM

The National Institutes of Health has finalized rules to reduce financial conflicts of interests among federally funded researchers who also receive payments or stock from drug and medical device companies, according to a report by the Washington Post.

More... »

FDA creates modernization plan

Tuesday, August 23, 2011 12:43 PM

The FDA is prioritizing development of technologies to compare biosimilars to innovator products in its plan to modernize regulatory science.

More... »

FDA approves first gene-targeted drug for Melanoma

Wednesday, August 17, 2011 12:05 PM

The FDA has approved Zelboraf, known as vemurafenib or PLX4032 during testing, well ahead of the approval deadline.  Zelboraf is the first drug to treat advanced melanoma by targeting a specific gene mutation.

More... »

FDA issues guidance to improve clinical study quality

Monday, August 15, 2011 01:40 PM

The FDA has issued draft guidance to help researchers and manufacturers design better quality clinical studies in support of premarket approval (PMA) applications for medical devices.

More... »

Regulatory requirements become more complex as clinical trials increase

Friday, August 12, 2011 10:45 AM

As pharmaceutical and biopharmaceutical companies increase the number of clinical trials they conduct in emerging global markets, growing regulatory complexity is forcing them to change the way they operate, experts have warned, according to PharmaTimes.

More... »